MedTrace Logo

Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients

NCT01758055 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-12-31

No results posted yet for this study

Summary

The purpose of this study is evaluating the safety of endobronchial transplantation of autologous mesenchymal stem cells derived bone marrow in patients with emphysema.

Conditions

  • Emphysema

Interventions

BIOLOGICAL

Autologous MSCs transplantation

Autologous mesenchymal stem cells derived bone marrow, bronchoscopy

Sponsors & Collaborators

  • Royan Institute

    collaborator OTHER_GOV

  • Arda Kiani

    lead OTHER

Principal Investigators

  • Arda Kiani, MD, pulmono · Tracheal Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

  • Naser Aghdami, MD,PHD · Department of Regenerative Biomedicine and cell therapy,Cell science Research Center,Royan Institute for Stem Cell Biology and Technology,ACER,Tehran,Iran

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758055 on ClinicalTrials.gov